Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple home workout and protein shake may keep seniors on their feet

NCT ID NCT03417531

Prevention Sponsor: University of Zurich Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a simple home exercise program and protein supplements, alone or together, could help prevent falls in seniors at risk of muscle loss (sarcopenia). Over 800 older adults with early signs of frailty or a recent fall took part. They were assigned to do strength or flexibility exercises and take either a protein or a placebo powder. The goal was to see if these easy-to-do steps could reduce falls and maintain independence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Protein supplement (Moltein® Ready-to-Shake) and home exercise program
What this could lead to
If successful, this could provide a simple, low-cost way for seniors to reduce fall risk and maintain muscle strength as they age.
What could go wrong
The study is completed but results are not yet widely confirmed. Benefits may vary depending on individual health and adherence to the program.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

801 people

The number who actually took part.

Started

Jun 2018

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

75 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * At least 1 of 5 frailty criteria, definition by Linda Fried: 1) weight loss of \> 4.5 kg in the last 12 months; 2) reduced grip strength in Martin Vigorimeter test: ♂ ≤ 64 kPa, ♀ ≤ 42 kPa; 3) standardized question on exhaustion as published by Fried et al.; 4) gait speed \< 1 m/s; 5) 6-minute walk test \< 300 meters and/or Injurious (any injury) low trauma fall in the last 12 months prior to enrollment * Reduced protein intake defined as a score ≤ 0.5 at item K of the Mini Nutritional Assessment (MNA) * Community-dwelling or assisted living Exclusion Criteria: * Mini-mental state examination (MMSE) \< 24 (inability to follow the study procedures and give written informed consent) * Inability to come to the trial centers * Inability to walk at least 3 meters with or without walking aid * Severe kidney impairment (Glomerular filtration rate \[GFR\] \< 30 ml/min) * Inability to follow exercise instruction or inability to take protein powder mixed in drink or food (test at baseline screening examination) * Severe gait impairment or diseases with a risk of recurrent falling (due to conditions such as, e.g. Parkinson's disease/syndrome, Hemiplegia after stroke, symptomatic stenosis of the spinal canal, polyneuropathy, epilepsy, recurring vertigo, recurring syncope) * Major visual or hearing impairment or other serious illness that would preclude participation (e.g. alcohol abuse, alcoholic disease) * Inability to read/speak/write in German (necessary to follow instructions incl. STRONG exercise manual) * Living in a nursing home * Contraindication to treatment (e.g. allergy) * Contraindication to the vitamin D standard of care therapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty kwashiorkor protein-energy malnutrition Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FALL Frailty Malnutrition; protein Sarcopenia

Contacts and locations

Locations

  • Centre on Aging and Mobility, University of Zurich and City Hospital Waid and Triemli

    Zurich, Canton of Zurich, 8037, Switzerland

  • University Geriatric Medicine Felix Platter, Basel

    Basel, Basel, 4012, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.